Skip to content
  • News
  • Compare
  • Capital
variis
  • Clinics
  • Companies
  • Protocols
  • Specialists
  • Events
  • Funds
  • Press
variis

Longevity intelligence for Singapore and Australia. Sourced and evidence-graded.

Directories

  • Clinics
  • Companies
  • Protocols
  • Specialists
  • Funds
  • Events

Read

  • Archive
  • Capital
  • Compare
  • Glossary

Markets

  • Singapore
  • Australia

variis

  • About
  • Editorial standards
  • AI transparency
  • Corrections
  • Press

Legal

  • Medical disclaimer
  • Privacy policy
  • Terms of service

AI-assisted reporting, human-reviewed. Every claim sourced and graded. Not medical advice.

© 2026 variis · Singapore · Australia

  1. Home
  2. Events
  3. Everlab closes an AU$65M Series A
Everlab Founding Team

Event

Everlab closes an AU$65M Series A

Australia · Capital

Type
Capital
Market
Australia
When
16 June 2026

What to watch

Why variis flagged this

Led by AirTree Ventures; total raised reaches roughly AU$80M, with the UK named as the next market.

Related

Entities in play

  • ClinicEverlab

Common questions

Everlab closes an AU$65M Series A: what happened?
Led by AirTree Ventures; total raised reaches roughly AU$80M, with the UK named as the next market.
Everlab closes an AU$65M Series A: when?
16 June 2026. variis records dates only to the precision the source published, so a date given here as a month or a year is not being rounded from something more exact.
Everlab closes an AU$65M Series A: who is involved?
Everlab
Everlab closes an AU$65M Series A: why does variis track it?
It is recorded as capital in Australia, one of the categories variis follows across the longevity market.

Keep reading

Related coverage from the newsroom.

Lecture hall session at NUS's Intensive Course on Healthy Longevity launched alongside its new Healthy Longevity Graduate Certificate Singapore.

Singapore · Industry

NUS launches healthy longevity graduate certificate

Morrow's founder Allen Law, argue that longevity care can move beyond elite clinics through lifestyle medicine and AI-powered approaches.

Singapore · Industry

Can longevity be designed for everyone, not just the wealthy?

Prof. Andrea B. Maier in a research laboratory at NUS, Co-Founder of the NUS Academy for Healthy Longevity, advancing Singapore's healthy longevity research.

Singapore · Industry

Singapore pushes clinical longevity care into the mainstream

Suggest an update

Last updated 5 September 2026

Every entity profile on variis is sourced. Not medical or investment advice.